Product Information
CHLORPROMAZINE 100 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.5915 per EA under NDC 63304011401. Its NADAC has been published 269 times since Jun 30, 2021.
FDA first approved this application on Oct 26, 2020.
Strength
100 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
63304011401
Classification
Generic
Dosage Form
TABLET, SUGAR COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CHLORPROMAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214256FDA Approved
10/26/2020
On Market Since
11/18/2020
Pharmacological Classes
Price Statistics
The NADAC for CHLORPROMAZINE 100 MG TABLET has been published 269 times since Jun 30, 2021, and over the history we have for it it has declined 79.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5915 per EA |
|---|---|
| All-time high | $3.8038 (Dec 15, 2021) |
| All-time low | $0.4771 (Oct 23, 2024) |
| 52-week high | $0.8020 |
| 52-week low | $0.5711 |
| Median price | $0.8020 |
| Average price | $1.2564 |
| Largest weekly change | +55.1% (Oct 18, 2023) |
| Weeks tracked | 269 |
| Tracking since | Jun 30, 2021 |
1W
N/A
1M
N/A
3M
-1.1%
6M
+0.3%
1Y
-21.6%
3Y
-30.2%
5Y
-79.7%
All
-79.1%
Last surveyed Aug 19, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ChlorproMAZINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ChlorproMAZINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phenothiazine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHLORPROMAZINE 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CHLORPROMAZINE 100 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.5915 per EA (NDC 63304011401), effective Aug 19, 2026.
How has the price of CHLORPROMAZINE 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for CHLORPROMAZINE 100 MG TABLET has declined 79.1%. It has been tracked across 269 weekly CMS publications since Jun 30, 2021.
What are the highest and lowest recorded NADAC prices for CHLORPROMAZINE 100 MG TABLET?
Since Jun 30, 2021, the NADAC for CHLORPROMAZINE 100 MG TABLET has ranged from a low of $0.4771 (Oct 23, 2024) to a high of $3.8038 (Dec 15, 2021), with a median of $0.8020 per EA.
Are there cheaper alternatives to CHLORPROMAZINE 100 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of CHLORPROMAZINE 100 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CHLORPROMAZINE 100 MG TABLET?
CHLORPROMAZINE 100 MG TABLET (NDC 63304011401) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.